Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease

Organic and Biomolecular Chemistry

Volumn 2, Issue 10, 2004, Pages 1518-1527

  Wright, Karen ^a   Guerreiro, Catherine ^a   Laurent, Isabelle ^a   Baleux, Françoise ^a   Mulard, Laurence A ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATES; CELL CULTURE; CONDENSATION; DISEASES; MOLECULES; PROTEINS; SYNTHESIS (CHEMICAL);

CARRIER PROTEINS; COUPLING CHEMISTRY; LIPOPOLYSACCHARIDES (LPS); NEOGLYCOPEPTIDES;

POLYPEPTIDES;

SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA FLEXNERI 2A;

BACTERIAL ANTIGEN; EPITOPE; GLUCOSE; GLYCOCONJUGATE; GLYCOPEPTIDE; LIPOPOLYSACCHARIDE; LYSINE; MALARIA VACCINE; N ACETYLGLUCOSAMINE; O ANTIGEN; OLIGOSACCHARIDE; PADRE 45; RECOMBINANT VACCINE; RHAMNOSE; VACCINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; GLYCOSYLATION; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SHIGELLA FLEXNERI; SYNTHESIS;

ACETYLGLUCOSAMINE; ANTIGENS, BACTERIAL; CARBOHYDRATE CONFORMATION; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GLUCOSE; GLYCOCONJUGATES; GLYCOPEPTIDES; GLYCOSYLATION; LIPOPOLYSACCHARIDES; LYSINE; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA VACCINES; MOLECULAR STRUCTURE; O ANTIGENS; OLIGOSACCHARIDES; OLIGOSACCHARIDES, BRANCHED-CHAIN; RHAMNOSE; SHIGELLA FLEXNERI; VACCINES, CONJUGATE; VACCINES, SYNTHETIC;

EID: 2942691798     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b400986j     Document Type: Article

References (76)

1. Part 12 of the series: Synthesis of ligands related to the O-specific polysaccharides of Shigella flexneri serotype 2a and Shigella flexneri serotype 5a. For part 11, see ref. 47.
2. R. Shields and W. Burnett, Zmtralbl. Bakteriol., 1898, 24, 817-828.
3. T. G. Keusch and M. L. Bennish, Shigellosis, Plenum Medical Book Company, New York, 1991, pp. 593-620.
4. K. L. Kotloff, J. P. Winickoff, B. Ivanoflf, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak and M. M. Levine, Bull. WHO, 1999, 77, 651-666.
5. M. U. Khan, Int. J. Epidemiol., 1985, 14, 607-613.
6. M. A. Salam and M. L. Bennish, Rev. Infect. Dis., 1991, 13, S332-S341.
7. S. Ashkenazi, M. May-Zahav, J. Sulkes and Z. Samra, Antimicrob. Agents Chemother., 1995, 39, 819-823.
8. E. R. Iversen, H. Colding, L. Petersen, R. Ngetich and G. D. Shanks, Trans. R. Soc. Trop. Med. Hyg., 1998, 92, 30-31.
9. B. A. Iwalokun, G. O. Gbenle, S. I. Smith, A. Ogunledun, K. A. Akinsinde and E. A. Omonigbehin, J. Health Popul. Nutr., 2001, 19, 183-190.
10. World, Health and Organization, Bull. W.H.O., 1987, 65, 17-25.
11. WHO, Wkly. Epidemiol. Rec., 1997, 72, 73-79.
12. T. S. Coster, C. W. Hoge, L. L. van der Verg, A. B. Hartman, E. V. Oaks, M. M. Venkatesan, D. Cohen, G. Robin, A. Fontaine-Thompson, P. J. Sansonetti and T. L. Hale, Infect. Immun., 1999, 67, 3437-3443.
13. L. F. Fries, A. D. Montemarano, C. P. Mallett, D. N. Taylor, T. L. Haie and G. H. Lowell, Infect. Immun., 2001, 69, 4545-4553.
14. J. H. Passwell, E. Harlev, S. Ashkenazi, C. Chu, D. Miron, R. Ramon, N. Farzan, J. Shiloach, D. A. Bryla, F. Majadly, R. Roberson, J. B. Robbins and R. Schneerson, Infect. Immun., 2001, 69, 1351-1357.
15. D. Cohen, M. S. Green, C. Block, T. Rouach and I. Ofek, J. Infect. Dis., 1988, 157, 1068-1071.
16. D. Cohen, M. S. Green, C. Block, R. Slepon and I. Ofek, J Clin. Microbiol., 1991, 29, 386-389.
17. A. Phalipon, M. Kauffmann, P. Michetti, J.-M. Cavaillon, M. Huerre, P. Sansonetti and J.-P. Krahenbuhl, J. Exp. Med., 1995, 182, 769-778.
18. J. B. Robbins, C. Chu and R. Schneerson, Clin. Infect. Dis., 1992, 15, 346-361.
19. D. N. Taylor, A. C. Trofa, J. Sadoff, C. Chu, D. Bryla, J. Shiloach, D. Cohen, S. Ashkenazi, Y. Lerman, W. Egan, R. Schneerson and J. B. Robbins, Infect. Immun., 1993, 61, 3678-3687.
20. D. Cohen, S. Ashkenazi, M. S. Green, M. Gdalevich, G. Robin, R. Slepon, M. Yavzori, N. Orr, C. Block, I. Ashkenazi, J. Shemer, D. N. Taylor, T. L. Hale, J. C. Sadoff, D. Pavliovka, R. Schneerson and J. B. Robbins, The Lancet, 1997, 349, 155-159.
21. R. W. Ellis and D. M. Granoff, Development and clinical use of Haemophilus b conjugate vaccines, M. Dekker, New York, 1994.
22. P. Richmond, R. Borrow, E. Miller, S. Clark, F. Sadler, A. Fox, N. Begg, R. Morris and K. Cartwright, J. Infect. Dis., 1999, 179, 1569-1572.
23. M. B. Rennels, K. M. Edwards, H. L. Keyserling, K. S. Reisinger, D. A. Hogerman, D. V. Madore, I. Chang, P. R. Paradiso, F. J. Malinoski and A. Kimura, Pediatrics, 1998, 101, 604-611.
24. V. Pozsgay, C. Chu, L. Panell, J. Wolfe, J. B. Robbins and R. Schneerson, Proc. Nail. Acad. Sci. USA, 1999, 96, 5194-5197.
25. B. Benaissa-Trouw, D. J. Lefeber, J. P. Kamerling, J. F. G. Vliegenthart, K. Kraaijeveld and H. Snippe, Infect. Immun., 2001, 69, 4698-4701.
26. F. Mawas, J. Niggemann, C. Jones, M. J. Corbet, J. P. Kamerling and J. F. G. Vliegenthart, Infect. Immun., 2002, 70, 5107-5114.
27. J. B. Robbins, R. Schneerson, S. C. Szu and V. Pozsgay in Polysaccharide-protein conjugate vaccines, ed. S. Plotkin and B. Fantini, Elsevier, Paris, 1996, pp. 135-143.
28. G. J. P. H. Boons, P. Hoogerhout, J. T. Poolman, G. A. van der Marel and J. H. van Boom, Bioorg. Med. Chem., 1991, 1, 303-308.
29. E. Lett, S. Gangloff, M. Zimmermann, D. Wachsmann and J.-P. Klein, Infect. Immun., 1994, 62, 785-792.
30. A. Kandil, N. Chan, M. Klein and P. Chong, Glycoconjugate J., 1997,14, 13-17.
31. T. Barington, M. Skettrup, L. Juul and C. Heilmann, Infect. Immun., 1993, 61, 432-438.
32. T. A. Barington, K. Gyhrs, K. Kristensen and C. Heilman, Infect. Immun., 1994, 62, 9-14.
33. C. C. A. M. Peeters, A.-M. Tenbergen-Meekes, J. T. Poolman, M. Beurret, B. J. M. Zegers and G. T. Rijkers, Infect. Immun., 1991, 59, 3504-3510.
34. M.-P. Schutze, C. Ledere, M. Jolivet, F. Audibert and L. Chedid, J. Immunol., 1985, 135, 2319-2322.
35. P. R. Paradiso, K. Dermody and S. Pillai, Vaccine Res., 1993, 2, 239-248.
36. D. Valmori, A. Pessi, E. Bianchi and G. P. Corradin, J. Immunol., 1992, 149, 717-721.
37. J. Alexander, J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, A. Sette and H. M. Grey, Immunity, 1994, 1, 751-761.
38. J. Alexander, A.-F. del Guercio, A. Maewal, L. Qiao, J. Fikes, R. W. Chesnut, J. Paulson, D. R. Bundle, S. DeFrees and A. Sette, J. Immunol., 2000, 164, 1625-1633.
39. S. Vichier-Guerre, R. Lo-Man, L. BenMohamed, E. Dériaud, S. Kovats, C. Leclere and S. Bay, J. Peptide Res., 2003, 62, 117-124.
40. D. A. R. Simmons, Bacteriol. Rev., 1971, 35, 117-148.
41. A. A. Lindberg, A. Karnell and A. Weintraub, Rev. Infect. Dis., 1991, 13, S279-S284.
42. J. M. Berry and G. G. S. Dutton, Can. J. Chem., 1974, 54, 681-683.
43. G. M. Lipkind, A. S. Shashkov, A. V. Nikolaev, S. S. Mamyan and N. K. Kochetkov, Bioorg. Khim., 1987, 13, 1081-1092.
44. C. Costachel, P. J. Sansonetti and L. A. Mulard, J. Carbohydr. Chem., 2000, 19, 1131-1150.
45. L. A. Mulard, C. Costachel and P. J. Sansonetti, J. Carbohydr. Chem., 2000, 19, 849-877.
46. F. Segat and L. A. Mulard, Tetrahedron: Asymmetry, 2002, 13, 2211-2222.
47. L. A. Mulard and C. Guerreiro, Tetrahedron, 2004, 60, 2475-2488.
48. F. Bélot, C. Costachel, K. Wright, A. Phalipon and L. A. Mulard, Tetrahedron. Lett., 2002, 43, 8215-8218.
49. F. Bélot, K. Wright, C. Costachel, A. Phalipon and L. A. Mulard, J. Org. Chem., 2004, 69, 1060-1074.
50. A. Phalipon, C. Costachel, A. Thuizat, F. Nato, B. Vulliez-Le Normand, V. Marcel-Peyre, G. Bentley, P. J. Sansonetti and L. A. Mulard, in preparation.
51. R. R. Schmidt and W. Kinzy, Adv. Carbohydr. Chem. Biochem., 1994, 50, 21-123.
52. R. R. Schmidt and J. Michel, Tetrahedron Lett., 1984, 25, 821-824.
53. R. R. Schmidt, J. Michel and M. Roos, Liebigs Ann. Chem., 1984, 1343-1357.
54. R. Gigg, S. Payne and R. Conant, J. Carbohydr. Chem., 1983, 2, 207-223.
55. T. Eklind, R. Gustafsson, A.-K. Tidén, T. Norberg and P.-M. Åberg, J. Carbohydr. Chem., 1996, 15, 1161-1174.
56. A. Chernyak, G. Sharma, L. Konokov, P. Krishna, A. Levinsky, N. Kochetkov and A. R. Rao, Carbohydr. Res., 1992, 223, 303-309.
57. R. U. Lemieux and H. Driguez, J. Am. Chem. Soc., 1975, 97, 4063-4069.
58. W. Stahl, U. Sprengard, G. Kretschmar and H. Kunz, Angew. Chem., Int. Ed., 1994, 33, 2096-2098.
59. N. M. Spikjer, C. A. Keuning and M. Hooglugt, Tetrahedron, 1996, 52, 5945-5960.
60. Q. Li, H. Li, Q.-H. Lou, B. Su, M.-S. Cai and Z.-J. Li, Carbohydr. Res., 2002, 337, 1929-1934.
61. I. Kitagawa, N. I. Baek, K. Ohashi, M. Sakagami, M. Yoshikawa and H. Shibuya, Chem. Pharm. Bull., 1989, 37, 1131-1133.
62. J. J. Oltvoort, C. A. A. van Boeckel, J. H. der Koning and J. H. van Boom, Synthesis, 1981, 305-308.
63. R. Gigg and C. D. Warren, J. Chem. Soc. C, 1968, 1903-1911.
64. P. Westerduin, P. E. der Haan, M. J. Dees and J. H. van Boom, Carbohydr. Res., 1988, 180, 195-205.
65. T. Ziegler, F. Bien and C. Jurish, Tetrahedron: Asymmetry, 1998, 9, 765-780.
66. K. B. Reimer, S. L. Harris, V. Varma and B. M. Pinto, Carbohydr. Res., 1992, 228, 399-414.
67. J. Zhang, J. M. Mao, H. M. Chen and M. S. Cai, Tetrahedron: Asymmetry, 1994, 5, 2283-2290.
68. J. C. Castro-Palomino, M. H. Rensoli and V. Verez Bencomo, J. Carbohydr. Chem., 1996, 15, 137-146.
69. D. H. Marrian, J. Chem. Soc. C, 1949, 1515-1516.
70. G. T. Hermanson, Bioconjugate techniques, Academic Press, New York, 1996, p. 148.
71. G. Ragupathi, R. R. Koganty, D. Qiu, K. O. Llyod and P. O. Livingston, Glycoconjugate J., 1998, 15, 217-221.
72. I. Shin, H. Jung and M. Lee, Tetrahedron Lett., 2001, 42, 1325-1328.
73. J. M. Peeters, T. G. Hazendonk, E. C. Beuvery and G. I. Tesser, J. Immunol. Methods, 1989, 120, 133-143.
74. W. C. Chan and P. D. White, Fmoc solid phase peptide synthesis, Oxford University Press, New York, 2000.
75. S. R. Chhabra, B. Hothi, D. J. Evans, P. D. White, B. W. Bycroft and W. C. Chan, Tetrahedron Lett., 1998, 39, 1603-1606.
76. H. F. Brugghe, H. A. M. Timmermans, L. M. A. van Unen, G. J. T. Hove, G. W. der. Werken, J. T. Poolman and P. Hoogerhout, Int. J. Peptide Protein Res., 1994, 43, 166-172.